These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30317535)

  • 1. Systemic Estrogen Use and Discontinuation After Alzheimer's Disease Diagnosis in Finland 2005-2012: A Nationwide Exposure-Matched Cohort Study.
    Tolppanen AM; Tiihonen M; Taipale H; Koponen M; Tanskanen A; Lavikainen P; Tiihonen J; Hartikainen S
    Drugs Aging; 2018 Nov; 35(11):985-992. PubMed ID: 30317535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of cardiovascular drug use before and after diagnosis of Alzheimer's disease.
    Vu M; Koponen M; Taipale H; Tanskanen A; Tiihonen J; Kettunen R; Hartikainen S; Tolppanen AM
    Int J Cardiol; 2020 Feb; 300():221-225. PubMed ID: 31810814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin discontinuation in persons with and without Alzheimer's disease.
    Vu M; Kettunen R; Tolppanen AM; Hartikainen S; Taipale H
    Eur J Clin Pharmacol; 2022 Jul; 78(7):1145-1153. PubMed ID: 35449421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incident hip fractures among community dwelling persons with Alzheimer's disease in a Finnish nationwide register-based cohort.
    Tolppanen AM; Lavikainen P; Soininen H; Hartikainen S
    PLoS One; 2013; 8(3):e59124. PubMed ID: 23527106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of antidepressant use in community-dwelling persons with and without Alzheimer's disease: 13-year follow-up.
    Puranen A; Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
    Int J Geriatr Psychiatry; 2017 Jan; 32(1):94-101. PubMed ID: 26924266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and Prevalence of Antiepileptic Medication Use in Community-Dwelling Persons with and without Alzheimer's Disease.
    Sarycheva T; Taipale H; Lavikainen P; Tiihonen J; Tanskanen A; Hartikainen S; Tolppanen AM
    J Alzheimers Dis; 2018; 66(1):387-395. PubMed ID: 30282366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of predictors of hip fracture and mortality after hip fracture in community-dwellers with and without Alzheimer's disease - exposure-matched cohort study.
    Tolppanen AM; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S
    BMC Geriatr; 2016 Dec; 16(1):204. PubMed ID: 27908278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of antidepressants among community-dwelling persons with Alzheimer's disease: a nationwide register-based study.
    Laitinen ML; Lönnroos E; Bell JS; Lavikainen P; Sulkava R; Hartikainen S
    Int Psychogeriatr; 2015 Apr; 27(4):669-72. PubMed ID: 25412711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incident ischaemic heart disease in persons with Alzheimer's disease in a Finnish nationwide exposure-matched cohort.
    Tolppanen AM; Kettunen R; Ahonen R; Soininen H; Hartikainen S
    Int J Cardiol; 2013 Dec; 170(2):195-201. PubMed ID: 24200309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospitalization after Oral Antibiotic Initiation in Finnish Community Dwellers with and without Alzheimer's Disease: Retrospective Register-Based Cohort Study.
    Järvinen H; Taipale H; Koponen M; Tanskanen A; Tiihonen J; Tolppanen AM; Hartikainen S
    J Alzheimers Dis; 2018; 64(2):437-445. PubMed ID: 29914029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cohort profile: the Finnish Medication and Alzheimer's disease (MEDALZ) study.
    Tolppanen AM; Taipale H; Koponen M; Lavikainen P; Tanskanen A; Tiihonen J; Hartikainen S
    BMJ Open; 2016 Jul; 6(7):e012100. PubMed ID: 27412109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of psychotropic drug use among persons with and without Alzheimer's disease in Finnish nationwide cohort.
    Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
    Eur Neuropsychopharmacol; 2014 Nov; 24(11):1729-37. PubMed ID: 25453487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the use of diabetes drugs among community-dwelling people with Alzheimer's disease.
    López-Rubio C; Koponen M; Lampela P; Taipale H; Tanskanen A; Bell JS; Tolppanen AM; Hartikainen S
    BMC Geriatr; 2021 Dec; 21(1):701. PubMed ID: 34911481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of cataract surgeries in people with and without Alzheimer's disease.
    Hokkinen K; Kaarniranta K; Jämsen E; Lampela P; Hartikainen S; Tolppanen AM
    Acta Ophthalmol; 2022 Feb; 100(1):68-73. PubMed ID: 33988311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of Alzheimer's disease among users of postmenopausal hormone therapy: A nationwide case-control study.
    Imtiaz B; Taipale H; Tanskanen A; Tiihonen M; Kivipelto M; Heikkinen AM; Tiihonen J; Soininen H; Hartikainen S; Tolppanen AM
    Maturitas; 2017 Apr; 98():7-13. PubMed ID: 28274328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiepileptic Drug Use Is Associated with an Increased Risk of Pneumonia Among Community-Dwelling Persons with Alzheimer's Disease-Matched Cohort Study.
    Taipale H; Lampela P; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen AM
    J Alzheimers Dis; 2019; 68(1):127-136. PubMed ID: 30775987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term use of opioids for nonmalignant pain among community-dwelling persons with and without Alzheimer disease in Finland: a nationwide register-based study.
    Hamina A; Taipale H; Tanskanen A; Tolppanen AM; Karttunen N; Pylkkänen L; Tiihonen J; Hartikainen S
    Pain; 2017 Feb; 158(2):252-260. PubMed ID: 28092324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors of pneumonia in persons with and without Alzheimer's disease: a matched cohort study.
    Järvinen H; Tolppanen AM; Hartikainen S
    BMC Geriatr; 2023 Apr; 23(1):227. PubMed ID: 37038120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hospital care and drug costs from five years before until two years after the diagnosis of Alzheimer's disease in a Finnish nationwide cohort.
    Taipale H; Purhonen M; Tolppanen AM; Tanskanen A; Tiihonen J; Hartikainen S
    Scand J Public Health; 2016 Mar; 44(2):150-8. PubMed ID: 26553247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Risk of Head Injuries Associated With Antipsychotic Use Among Persons With Alzheimer's disease.
    Tapiainen V; Lavikainen P; Koponen M; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen AM
    J Am Geriatr Soc; 2020 Mar; 68(3):595-602. PubMed ID: 31912482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.